reason report
in-lin initi guid challeng loss new pt
bottom line reiter op rate pt
lower ep reflect transient strand sg
pressur earli termin contract
solid particularli import integr medic segment
though upsid off-set season claim pressur
revenu ep guidanc came lower
expect earlier expect strand pressur
loss contract ci offset contract loss
simultan onboard ci pbm membership optum rx
transit expect complet encourag
compani re-affirmed ep howev
simultan loss onboard ci pbm optum rx
integr esrx present oper challeng
basi modest pt lower rather transient
pressur see fear hh rebat propos overblown
pbm/mco lobbi import seat tabl
opposit hous leadership earliest probabl
watered-down propos like commerci rebat chang
requir act congress link link cfo also modestli
challeng earli termin contract though
compani fulli expect debt cap month model
reflect report chang post-esrx ep
lower ep lower ep
pt offer upsid contempl p/
 averag ep ci host investor
day may
solid though in-lin upsid integr medic
off-set season claim pressur ci report
larg in-lin ep margin compress
segment season claim offset solid
perform integr medic consolid
compar consensu sg compar
consensu cfo ni tax rate compar
consensu exhibit
revenu guidanc ep initi
guidanc exclud share repurchas prior
period develop lower expect strand
sg earlier expect termin contract
surpris neg expect guidanc conservat
beat rais bull case medic membership growth
guidanc exhibit
average
net debt total capit
price-to-earnings lt ep growth
share outstand mil share outstand
estimate lt ep growth compound-annual-growth-rate
year price history/av daili volume mil ci
compani inform svb leerink llc research
revenu ep forma ci-esrx ex-antm
revenu billion ep exclud item non-gaap ep
pleas refer page analyst certif import disclosur price chart disclosur specif
cover compani statement valuat risk avail
ep guidanc re-affirmed though oper
challeng pbm transit across loss
simultan transfer ci optum rx pbm esrx
integr substanti renew sell season juli
must contempl drug cost save enjoy
employe commerci stronghold
transit optum rx continu transform
journey ci esrx togeth must show path
revenu growth post integr may i-day
cfo challeng also loss contract though
debt cap re-affirmed within month
today potenti share repurchas tuck-in may
lower compani focus primarili debt paydown exhibit
lower ep ep
reflect strand challeng ep
consist guidanc model recast align
new report segment exhibit
see risk rebat propos hh overblown
pbm/mco lobbi import seat tabl
opposit hous leadership earliest probabl
watered-down propos like commerci rebat
chang requir act congress esrx disclos rebat
exposur mid-singl digit mm engag pilot
employ new formulari design contract model link
link analysi exhibit
pt goe reflect multipl oper
move part contempl price-to-earnings averag
ep ci host i-day may exhibit
reiter op rate pt lower ep reflect
transient strand sg pressur earli termin contract
solid particularli import integr medic segment though
upsid off-set season claim pressur revenu ep
guidanc came lower expect earlier expect strand
 pressur loss contract ci offset contract loss
simultan onboard ci pbm membership optum rx transit expect
complet encourag compani re-affirmed ep
howev simultan loss onboard ci pbm optum rx
integr esrx present oper challeng basi modest pt
lower rather transient pressur see fear hh rebat propos
overblown pbm/mco lobbi import seat tabl opposit
hous leadership earliest probabl watered-down propos like
commerci rebat chang requir act congress
cfo also modestli challeng earli termin contract though
compani fulli expect debt cap month model reflect
report chang post-esrx ep lower ep lower
ep pt offer upsid contempl
price-to-earnings averag ep ci host investor day may
solid though in-lin upsid integr medic off-set season claim
pressur
ci report larg in-lin ep margin compress segment
season claim offset solid perform integr medic consolid
compar consensu sg compar consensu cfo
ni tax rate compar consensu
solid though in-lin ep upsid integr medic off-set season claim
pressur intern
ci earningsreport leerink estimatesstreetaccount consensusreport sequentialreport yoytot net pre tax incom loss disabl pre tax incom loss operations/ disabl ci metricsreport leerink estimatesstreetaccount consensusreport yoykey metricsconsolid bpsglobal healthcar oper expens bpstotal oper expens bpsday claim corpor
ci membershipreport leerink estimatesstreetaccount consensusreport sequentialreport yoyhealth enrollmentcommerci custom integr health care medic medic membershipmedicar part corpor
ci qsum segment adj incom oper pre-tax
report sequentialreport incom oper pre margin pre servicesadj incom oper pre margin pre incom oper pre margin pre disabl operationsadj incom oper pre margin pre cigna corpor
dcp day though compar seq due segment realign
revenu guidanc ep initi guidanc
exclud share repurchas prior period develop lower
expect strand sg earlier expect termin
contract surpris neg expect guidanc conservat beat rais
bull case medic membership growth
initi guidanc consensu revenu ep initi guidanc
modestli consensu adjust revenu
compar street guidanc reflect earlier expect loss
claim payabl corpor
ci revenu guidanc ep guid includ headwind due
earli termin contract headwind
ci guidanceguid leerink estimatesconsensu estimatesconsolid revenueadjust expens incom incom oper pre-tax integr incom oper pre-tax supplement benefit mm adjust pharmaci claim adj net incom mm tax guidanc exclud share think million amount strand associ transit time earn per share ultim busi transit get cost system track final exact time play term cost come year versu next year anthem take work transit plan touch eric palmer cfo evp cigna corp call corpor
ep guidanc re-affirmed though oper challeng
pbm transit across loss simultan transfer ci optum rx
pbm esrx integr substanti renew sell season juli must
contempl drug cost save enjoy employe
commerci stronghold transit optum rx continu
transform journey ci esrx togeth must show path revenu growth
post integr may i-day
earli termin contract headwind
close let briefli comment outlook growth chassi proven track record deliveri provid multipl path sustain growth beyond expect revenu growth attract ep growth strong free cash flow posit us deliv averag annual ep growth next three year enabl us achiev ep target bridg think today tri articul three major build block get per share underli base perform asset synergi eric made refer articul million tax synergi impact de-lever alreadi board de-lever path basic cross-walk michael cordani presid ceo director cigna corp call corpor
guid accret driven entir mm administr synergi
cfo challeng also loss contract though debt cap
re-affirmed within month today potenti share repurchas
tuck-in may lower compani focus primarili debt paydown
re-affirmed debt capit month
debt capit
end debt-tocapit ratio previous discuss top capit deploy prioriti acceler debt repay object return debt-to-capit ratio debt-to-ebitda ratio within next month project capit avail deploy approxim billion expect deploy approxim billion debt repay approxim billion capit expenditur eric palmer cfo evp cigna corp debt capit corpor
mid- high-singl digit yield
lower ep given commentari headwind earli
contract termin also lower ep estim
lower ep ep
see risk rebat propos hh overblown pbm/mco lobbi
import seat tabl opposit hous leadership
earliest probabl watered-down propos like commerci rebat
chang requir act congress esrx disclos rebat exposur mid-singl
digit mm engag pilot employ new formulari design
contract model link link analysi
pleas see link note link
ci file disclos mm retain rebat spend esrx inclus commerci impli
lower pt
pt goe reflect multipl oper move part contempl
price-to-earnings averag ep ci host i-day may
ci trade ep
ci trade ep
cigna inc ci incom mail order pharmaci invest invest gain revenu expenseshealth care medic claim benefit mail order pharmaci cost good acquisit oper expens exclud special deal synergi benefit continu oper incom tax net growth yoyrevenu growth metricstot adj gdr gener dispens corpor
health enrol access/oth guarante guarante legaci servic great west medic membership without medic membership medic membership gw corpor
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans
pt contempl price-to-earnings averag ep
risk invest thesi valuat
legisl regulatori polici chang could either dis-intermedi
insur us benefit marketplac place unforeseen top-lin margin
headwind commerci medicar advantag medicaid dual elig book
not-for-profit health insur price irrat commerci health benefit
acceler employ exit sponsorship health benefit us
marketplac post implement afford act
advers select public exchang protect adequ given delay
true-up govern payment
acquisit asset without attract return capit investor
organiz and/or oper risk drive execut mis-step downsid risk
earn
primari valuat methodolog base absolut price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform dcf valuat
leverag forward forecast wacc termin growth rate inform
potenti multipl expans along sector compani specif catalyst expect
greater potenti multipl expans dcf valuat point significantli upsid
peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans
price target base price-to-earnings averag ep
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti econom downturn
provid re-up intens servic deliveri cobra acceler uptak
member util care advanc layoff pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz econom downturn
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus
longer term state-bas insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress potenti downsid membership
polit shock lead singl payer
compani specif risk signific declin equiti market could result increas fund
compani pension oblig polit legal oper regulatori econom
risk foreign oper
integr regulatori risk across merg ci esrx
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans price target base case
ep estim
risk valuat includ
start-up cost underwrit issu associ new busi on-board
particularli challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state
legisl regulatori judici polici chang medicaid entitl program
state feder suprem court level also risk consid
pt contempl price-to-earnings consensu ep
price-to-earnings ep expect synergi across administr effici
retail steerag aet member benefit design chang floor rebat reduct
store base distribut part polici drive upsid estim also
multipl expans pt
underwrit risk aet asset trade peak margin commerci fulli
insur though medacorp commerci broker price survey give us confid
price environ remain appropri hard offer flat even potenti
modestli expand underwrit margin risk potenti futur margin compress
aet health insur even meaning given associ neg impact
debt ebitda load compani need focus debt
pay next month departur shawn guertin aet cfo
slate becom cfo make us less confid price postur
health insur book commenc new bulk compet
share gain commerci medicar advantag market
macroeconom risk risk macroeconom downturn higher
defens pbm sub sector given cyclic correl retail front store
sale employ data
regulatori risk convinc pbm add valu earn
low probabl threat potenti drug manufactur rebat elimin off-set
new busi model includ administr fee and/or perform guarante
expos pbm retail pharmaci busi compar
player pbm risk
execut integr risk face greater risk well given integr
pbm broader organ also transform agenda around
build retail front model amid risk leverag balanc sheet
e-commerce/amzn greater exposur eros sale on-line
channel well given exposur retail front store retail pharmaci e-
commerc though larg price retail multipl expect less like
pursu agenda becom pbm given associ integr clinic evid
base treatment guidelin integr provid network domin captiv pbm
model mega deal
remain posit reiter op rate month pt
contempl price-to-earnings ep
risk invest thesi valuat legisl regulatori
polici chang could either dis-intermedi health insur us benefit
marketplac place unforeseen top-lin margin headwind commerci medicar
advantag medicaid dual elig book busi not-for-profit health insur
price irrat commerci health benefit marketplac acceler employ exit
sponsorship health benefit us marketplac post implement
afford act advers select public exchang protect adequ
given delay true-up govern payment acquisit asset
without attract return capit investor organiz and/or oper risk
lead execut mis-step downsid risk earn acceler medic cost
trend util improv economi
pt reflect price-to-earnings ep
start-up cost underwrit issu associ new busi on-board
particularli challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state
legisl regulatori judici polici chang medicaid
scale issu result loss specialti rx pharmaci contract
acquisit offer adequ return capit
upsid takeout substanti premium key risk
carve-out behavior health servic current state contract
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
base post month turnaround rate outperform pt
contempl price-to-earnings ep
risk highlight first spike util on-board new state contract
dual elig integr second state-bas insur exchang result advers
select reduc sustain earn power third state-bas contract rate increas
suffici cover medic trend off-set industri fee medicaid premium fourth risk re-
procur exist contract could creat substanti downsid risk volatil fifth
legisl judici risk manag medicaid entitl extrem case singl
payer model also possibl downsid
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
rate outperform price target contempl price-to-earnings
cash ep
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti double-dip recess
provid re-up intens servic deliveri cobra acceler uptak member util
care advanc lay-off pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz double-dip recess
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus substanti
long-term state base health insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress also potenti downsid membership
risk relat collect industri fee medicar medicaid premium
polit shock lead singl payer
compani specif risk downsid risk price target includ acquisit asset
arena yield adequ return capit
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free yield ratio also inform potenti multipl expans
except low ratio and/or high free yield point potenti greater
base rate wcg outperform pt contempl price-to-earnings
ep
downsid risk price target includ execut new state contract dual elig
award rate increas suffici cover medic trend state clawback tax off-set tax
reform tailwind potenti dial medicaid expans ky upsid risk price
target includ take-out larger player
